PharmaEssentia Statistics
Total Valuation
PharmaEssentia has a market cap or net worth of EUR 5.55 billion. The enterprise value is 4.97 billion.
Market Cap | 5.55B |
Enterprise Value | 4.97B |
Important Dates
The last earnings date was Monday, November 11, 2024.
Earnings Date | Nov 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +11.12% |
Shares Change (QoQ) | -0.22% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 255.72M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 120.57, with an EV/FCF ratio of 402.60.
EV / Earnings | 95.41 |
EV / Sales | 20.42 |
EV / EBITDA | 120.57 |
EV / EBIT | 159.93 |
EV / FCF | 402.60 |
Financial Position
The company has a current ratio of 12.31, with a Debt / Equity ratio of 0.04.
Current Ratio | 12.31 |
Quick Ratio | 11.53 |
Debt / Equity | 0.04 |
Debt / EBITDA | 0.73 |
Debt / FCF | 2.34 |
Interest Coverage | 46.32 |
Financial Efficiency
Return on equity (ROE) is 7.39% and return on invested capital (ROIC) is 2.57%.
Return on Equity (ROE) | 7.39% |
Return on Assets (ROA) | 2.37% |
Return on Capital (ROIC) | 2.57% |
Revenue Per Employee | 1.79M |
Profits Per Employee | 397,764 |
Employee Count | 131 |
Asset Turnover | 0.30 |
Inventory Turnover | 0.77 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +67.16% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +67.16% |
50-Day Moving Average | 20.07 |
200-Day Moving Average | 15.65 |
Relative Strength Index (RSI) | 34.96 |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PharmaEssentia had revenue of EUR 234.87 million and earned 52.11 million in profits. Earnings per share was 0.16.
Revenue | 234.87M |
Gross Profit | 204.58M |
Operating Income | 30.00M |
Pretax Income | 54.42M |
Net Income | 52.11M |
EBITDA | 33.07M |
EBIT | 30.00M |
Earnings Per Share (EPS) | 0.16 |
Balance Sheet
The company has 588.07 million in cash and 28.86 million in debt, giving a net cash position of 559.22 million.
Cash & Cash Equivalents | 588.07M |
Total Debt | 28.86M |
Net Cash | 559.22M |
Net Cash Per Share | n/a |
Equity (Book Value) | 736.35M |
Book Value Per Share | 2.22 |
Working Capital | 640.55M |
Cash Flow
In the last 12 months, operating cash flow was 43.39 million and capital expenditures -31.04 million, giving a free cash flow of 12.35 million.
Operating Cash Flow | 43.39M |
Capital Expenditures | -31.04M |
Free Cash Flow | 12.35M |
FCF Per Share | n/a |
Margins
Gross margin is 87.10%, with operating and profit margins of 12.77% and 22.19%.
Gross Margin | 87.10% |
Operating Margin | 12.77% |
Pretax Margin | 23.17% |
Profit Margin | 22.19% |
EBITDA Margin | 14.08% |
EBIT Margin | 12.77% |
FCF Margin | 5.26% |
Dividends & Yields
PharmaEssentia does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -11.12% |
Shareholder Yield | -11.12% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
PharmaEssentia has an Altman Z-Score of 29.42.
Altman Z-Score | 29.42 |
Piotroski F-Score | n/a |